[go: up one dir, main page]

WO2001070997A3 - Regulation de l'enzyme du type leucine aminopeptidase humaine - Google Patents

Regulation de l'enzyme du type leucine aminopeptidase humaine Download PDF

Info

Publication number
WO2001070997A3
WO2001070997A3 PCT/EP2001/003331 EP0103331W WO0170997A3 WO 2001070997 A3 WO2001070997 A3 WO 2001070997A3 EP 0103331 W EP0103331 W EP 0103331W WO 0170997 A3 WO0170997 A3 WO 0170997A3
Authority
WO
WIPO (PCT)
Prior art keywords
leucine aminopeptidase
regulation
enzyme
human leucine
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/003331
Other languages
English (en)
Other versions
WO2001070997A2 (fr
Inventor
Shyam Ramakrishnan
Yonghong Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to EP01915412A priority Critical patent/EP1268814A2/fr
Priority to AU2001242512A priority patent/AU2001242512A1/en
Publication of WO2001070997A2 publication Critical patent/WO2001070997A2/fr
Publication of WO2001070997A3 publication Critical patent/WO2001070997A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des réactifs qui permettent de réguler l'activité de l'enzyme du type leucine aminopeptidase humaine, ainsi que des réactifs qui se lient à des produits géniques d'enzyme du type leucine aminopeptidase. Ces réactifs peuvent servir à réguler la dégradation polypeptidique cellulaire et extracellulaire. Une telle régulation est particulièrement utile pour traiter cancer, VIH, maladie auto-immune et pressions artérielles élevées.
PCT/EP2001/003331 2000-03-24 2001-03-23 Regulation de l'enzyme du type leucine aminopeptidase humaine Ceased WO2001070997A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01915412A EP1268814A2 (fr) 2000-03-24 2001-03-23 Regulation de l'enzyme du type leucine aminopeptidase humaine
AU2001242512A AU2001242512A1 (en) 2000-03-24 2001-03-23 Regulation of human leucine aminopeptidase-like enzyme

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19171600P 2000-03-24 2000-03-24
US60/191,716 2000-03-24

Publications (2)

Publication Number Publication Date
WO2001070997A2 WO2001070997A2 (fr) 2001-09-27
WO2001070997A3 true WO2001070997A3 (fr) 2002-02-28

Family

ID=22706648

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/003331 Ceased WO2001070997A2 (fr) 2000-03-24 2001-03-23 Regulation de l'enzyme du type leucine aminopeptidase humaine

Country Status (3)

Country Link
EP (1) EP1268814A2 (fr)
AU (1) AU2001242512A1 (fr)
WO (1) WO2001070997A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535241A1 (fr) * 1991-04-08 1993-04-07 Suntory Limited Nouvelle leucine-aminopeptidase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535241A1 (fr) * 1991-04-08 1993-04-07 Suntory Limited Nouvelle leucine-aminopeptidase

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL SEQUENCE LIBRARY 12 April 1997 (1997-04-12), NCI-CGAP: ""National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index http://www.ncbi.nlm.nih.gov/ncicgap";", XP002182943 *
DATABASE EMBL SEQUENCE LIBRARY 13 June 1997 (1997-06-13), HILLIER, L., ET AL.: "WashU-Merck EST project 1997", XP002182942 *
DATABASE EMBL SEQUENCE LIBRARY 14 March 1995 (1995-03-14), NONE: ""Genome sequence of the nematode C. elegans: a platform for investigating biology. The C. elegans Sequencing Consortium" - Caenorhabditis elegans cosmid B0495, complete sequence", XP002182941 *
DATABASE SWALL-DATABASE 1 November 1997 (1997-11-01), KIRSTEN, J.: "HYPOTHETICAL 98.3 KDA PROTEIN B0495.7 IN CHROMOSOME II. - Caenorhabditis elegans.", XP002182940 *
HATTORI AKIRA ET AL: "Molecular cloning of adipocyte-derived leucine aminopeptidase highly related to placental leucine aminopeptidase/oxytocinase", JOURNAL OF BIOCHEMISTRY, JAPANESE BIOCHEMICAL SOCIETY, TOKYO, JP, vol. 125, no. 5, May 1999 (1999-05-01), pages 931 - 938, XP002155174, ISSN: 0021-924X *

Also Published As

Publication number Publication date
EP1268814A2 (fr) 2003-01-02
AU2001242512A1 (en) 2001-10-03
WO2001070997A2 (fr) 2001-09-27

Similar Documents

Publication Publication Date Title
WO2002042445A3 (fr) Cellules differenciees utilisables en therapie d'un individu humain
WO2002061090A3 (fr) Anticorps produits de maniere procaryote et utilisations de ceux-ci
WO2003018771A3 (fr) Systeme d'expression d'anticorps et ensemble
WO2002074979A3 (fr) Profils d'expression et methodes d'utilisation
WO2003099771A3 (fr) Derives de diaryle-uree utilises pour le traitement des maladies dependant des proteines kinases
WO2001083782A3 (fr) Nouvelles proteases
ATE174599T1 (de) Bindungskompetente oligomere, die 2',5'-bindungen enthalten
GB0309765D0 (en) A cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium, as well as its uses.
WO2002053170A3 (fr) Utilisation combinee d'inhibiteurs enzymatiques et de preparations pharmaceutiques constituees de ces inhibiteurs pour le traitement et la prophylaxie de l'arteriosclerose, pour le traitement et la prevention de reactions allergiques de type i selon la classification de gell et coombs et pour le traitement et la prevention
WO2002049593A3 (fr) Utilisation d'enzymes de reparation de l'adn en tant qu'inhibiteurs de mmp-1
WO1998051799A1 (fr) Nouvel inhibiteur de differentiation
WO2004098634A3 (fr) Proteine arginine n-methyltransferase 2 (prmt-2)
WO2002042326A8 (fr) Procede d'expression et agents identifies a l'aide de ce dernier
WO2000009553A3 (fr) Peptides antimicrobiens isoles a partir de la peau de grenouilles americaines
WO1998059040A3 (fr) Sous-unite de telomerase catalytique humaine et son utilisation therapeutique et diagnostique
EP1236465A3 (fr) Utilisation de produits de légumes pour traiter des atteintes extérieures
WO2000037487A8 (fr) INHIBITEURS DE L'INTEGRINE $G(a)v$G(b)¿6?
WO2001036465A3 (fr) Proteines humaines zven
WO2003044037A3 (fr) Procede de fabrication de leucocytes phagocytaires mononucleaires humains
WO2001070997A3 (fr) Regulation de l'enzyme du type leucine aminopeptidase humaine
WO2023205793A3 (fr) Protéines de liaison à siglec-8 et leurs utilisations
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
MY132553A (en) Methods of making hiv-protease inhibitors and intermediates for making hiv-protease inhibitors
IL129922A0 (en) Tissue specific expression of retinoblastoma protein
WO2003070878A3 (fr) Modulation anti-sens de l'expression des proteines tyrosine kinase de cellules hematopoietiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001915412

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10239422

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001915412

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001915412

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP